首页 › 狼疮 › 纽约州 › New York City
New York City NY 狼疮临床试验
18项针对 狼疮的研究正在 New York City及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
招募中2 期
- Columbia University Medical Center, New York
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
招募中1 期
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- NYP/Weill Cornell Medical Center, New York
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
招募中3 期
- Sl0044 50077, New York
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
招募中3 期
- Research Site, New York
HEALTH Home Urinalysis Testing
招募中
- NYU Langone Health, New York
A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
招募中1/2 期
- Research Site, New York
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
招募中1 期
- Icahn School of Medicine at Mount Sinai, New York
A Study to Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132
招募中4 期
- New York University School Of Medicine, New York
Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)
招募中2 期
- Icahn School of Medicine at Mount Sinai, New York
Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease
招募中3 期
- VA NY Harbor Healthcare System, New York
- NYC Health + Hospitals/Bellevue, New York
- NYU Langone Health, New York
- 以及另外 2 项
Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
招募中2 期
- NYU Langone Health, New York
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
招募中1 期
- Columbia University Medical Center, New York
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
招募中1 期
- Montefiore Medical Center, New York
Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)
招募中观察性研究欢迎健康志愿者
- NYU Langone Medical Center/Hospital for Joint Diseases, New York
- Hospital for Special Surgery, New York
Alnuctamab for Refractory SLE (LATTE Study)
招募中1 期
- Icahn School of Medicine at Mount Sinai, New York
Lupus Landmark Study: A Prospective Registry and Biorepository
招募中观察性研究
- Columbia University Medical Center, New York
- Northwell Health, New York
Safety of the Herpes Zoster Subunit Vaccine in Lupus
招募中4 期
- NYU Langone Health, New York
Safety and Efficacy of ONT01 in Lupus
招募中早期 I 期
- Hospital for Special Surgery, New York
其他城市的 狼疮试验
- Houston, TX13 项研究
- Durham, NC12 项研究
- Miami, FL11 项研究
- Washington, DC10 项研究
- Tampa, FL9 项研究
- Philadelphia, PA9 项研究
- Clearwater, FL8 项研究
- Santa Monica, CA8 项研究
- Oklahoma City, OK8 项研究
- Los Angeles, CA8 项研究
- Boston, MA8 项研究
- Chicago, IL8 项研究
New York City的其他研究
- 乳腺癌136 项研究
- 非小细胞肺癌121 项研究
- 癌症（所有类型）109 项研究
- 前列腺癌103 项研究
- 转移性癌症93 项研究
- 结直肠癌78 项研究
- 卵巢癌69 项研究
- 肺癌60 项研究
- 多发性骨髓瘤60 项研究
- 胰腺癌60 项研究
- 子宫内膜癌52 项研究
- 急性髓系白血病51 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。